Biomimetic Lipid-polymer composite membrane model to study Permeability through Cornea

Abstract

The excised animal cornea is the gold standard for testing and evaluating drug permeability through a cornea. However, it has a concise shelf life and encounters ethical concerns. Also, ex-vivo models, which are incomplete replicas of the human cornea, may provide faulty results in the pre-clinical studies. To circumvent these problems, we have proposed an in-vitro biomimetic lipid-polymer composite membrane (BLCM) model as an artificial cornea to study drug permeability. We designed and fabricated a free-standing, electro-spun polystyrene (PS) nanofibrous membrane and impregnated its pores with phosphatidylcholine (PC). SEM, FTIR, and goniometer characterized the BLCM. Permeation data of the drug ganciclovir through the BLCM model in a Franz-diffusion cell corroborates with the excised goat corneal system. Also, owing to the simple and scalable fabrication method, BLCM can be used as an alternative to animal models for initial drug permeability screening and studies and accelerate drug development.